Newell Brands Inc. (NYSE:NWL)
Newell Brands Inc. (NYSE:NWL) represented a move of -2.98 percent or $0.68 per share and closed its previous day trading session at $15.94. 14.47 Million Shares were traded in the last trading session with an Average Volume of 9.15 Million Shares. The stock currently has a Market Capitalization of 7.75 Billion.
Newell Brands is a leading global consumer goods company with a strong portfolio of well-known brands, including Paper Mate, Sharpie, Dymo, EXPO, Parker, Elmer?s, Coleman, Jostens, Marmot, Rawlings, Oster, Sunbeam, FoodSaver, Mr. Coffee, Rubbermaid Commercial Products, Graco, Baby Jogger, NUK, Calphalon, Rubbermaid, Contigo, First Alert, Waddington and Yankee Candle. The company’s headquarters are in Hoboken, New Jersey.
The stock traded between $15.88 and $41.31 over 1-Year time period showing its price to sales ratio of 0.68. Newell Brands Inc. (NYSE:NWL) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-21.85 and 200-Day Simple Moving Average of $-36.51. Its Price to Free Cash Flow is 104.31 and Price to Book of 0.56.
Analyst’s recommended the stock as 2.7 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Newell Brands Inc. (NYSE:NWL) reported its Actual EPS of $0.82/share. The analysts offering Earnings Estimates for the company were believing that Newell Brands Inc. could bring EPS of $0.78/share. The difference between Actual EPS and Estimated EPS was 0.04 Percent. Thus showing an Earnings Surprise of 5.1 Percent.
Merck & Company, Inc. (NYSE:MRK)
In the last trading session, Merck & Company, Inc. (NYSE:MRK) added its value by -2.16% closing at the price of $70.54. The stock currently has market capitalization of 189.26 Billion, with average volume of 8.7 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Merck & Company, Inc. (NYSE:MRK) is showing beta of 0.83. This particular value of beta suggests that Merck & Company, Inc. (NYSE:MRK) has historically moved 83% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Merck & Company, Inc. (NYSE:MRK) is at $1.46.
The stock currently has RSI of 48.01. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
Merck & Company, Inc. (NYSE:MRK) topped its 52-week high price of $73.49 on 10/22/18 and 52-Week Low Price of $52.83 on 04/03/18. The Stock currently has P/E (price to earnings ttm) of 48.41 and Weekly volatility of 1.95% and monthly volatility of 1.92% respectively.